The aim of the study is to investigate the role of exercise-induced IL-6 in regulating energy stores and energy metabolism during recovery after an acute exercise bout. To achieve this, 30 men will be randomized to infusion placebo or tocilizumab (IL-6 receptor antibody) combined with a 2-hour exercise bout. Stable isotope tracers will be infused to determine substrate kinetics. Indirect calorimetry will be applied to determine substrate oxidation, and muscle biopsies will be taken to determine substrate uptake and storage.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in muscle glycogen content (mmol/kg/h)
Timeframe: Measured at 0, 120, 180 and 360 minutes
Change in muscle triglycerides content
Timeframe: Measured at 0, 120, 180 and 360 minutes
Change in muscle expression of glucose transporter type 4 (GLUT4)
Timeframe: Measured at 0, 120 and 360 min
Change in muscle expression of fatty acid translocase (FAT/CD36)
Timeframe: Measured at 0, 120 and 360 min
Change in muscle expression of muscle fatty acid binding protein (FABPm)
Timeframe: Measured at 0, 120 and 360 min
Change in muscle expression of fatty acid transporter 4 (FATP4)
Timeframe: Measured at 0, 120 and 360 min
Change in muscle expression of glycerol transporters
Timeframe: Measured at 0, 120 and 360 min